RAIDS atlas of significant genetic and protein biomarkers in cervical cancer.

Scholl, Suzy; Roufai, Diana Bello; Chérif, Linda Larbi; Kamal, Maud

Scholl, Suzy; Roufai, Diana Bello; Chérif, Linda Larbi; Kamal, Maud.

Affiliation

Scholl S; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.
Roufai DB; Department of Drug Development and Innovation (D3i), Institut Curie, Saint-Cloud, France. suzy.scholl@curie.fr.
Chérif LL; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.

J Gynecol Oncol ; 34(5): e74, 2023 09.

Article in En | MEDLINE | ID: mdl-37668079

Subject(s)

Breast Neoplasms; Carcinoma, Squamous Cell; Uterine Cervical Neoplasms; Female; Humans; Uterine Cervical Neoplasms/genetics; Uterine Cervical Neoplasms/therapy; Carcinoma, Squamous Cell/genetics; Carcinoma, Squamous Cell/therapy; Biomarkers; Chemoradiotherapy

Key words

Chemoradiation; Post Translational Protein Modifications; Targeted Treatments; Treatment Combinations; BioRAIDs; Genetic & Proteomic Biomarkers

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Carcinoma, Squamous Cell / Uterine Cervical Neoplasms Limits: Female / Humans Language: En Journal: J Gynecol Oncol Year: 2023 Type: Article Affiliation country: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google